title: Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
authors.affiliation: Institute of Human Virology , University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Polk
authors.forename: Kirk M
authors.initials: KM
authors.lastname: Chan-Tack
authors.forename: Angela M
authors.initials: AM
authors.lastname: Kopack
authors.forename: Anthony
authors.initials: A
authors.lastname: Amoroso
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068679:Emtricitabine; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D061466:Lopinavir; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use; D000068698:Tenofovir; D019562:Viral Load; D014766:Viremia
chemical_list: D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D063065:Organophosphonates; D010446:Peptide Fragments; D011744:Pyrimidinones; D003841:Deoxycytidine; D000077560:Enfuvirtide; D061466:Lopinavir; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; D019438:Ritonavir